[1] Billroth Theodor. Die allgemeine chirurgische Pathologie und Therapie in 51 Vorlesungen:Ein Handbuch für Studirende und Aerzte[M].De Gruyter:1906-12-31.
[2] Fante R,Roncucci L,Di Gregoril C,et al.Frequence and elinical features of multiple tumor of the large bowel in the general population with hereditary colorectal carcinoma [J]. cancer, 1996, 77 (10):2013-2021.
[3] Kamat AM,Hahn NM,Efstathiou JA,et al. Bladde cancer[J].Lancet,2016,388(10061):2796-2810.
[4]Shinko D, Diakos CI, Clarke SJ, et al. Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine[J]. Clin Pharmacol Ther, 2017, 102(4):599-610.
[5]Romero-Cordoba, Meneghini, Sant, et al. Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation[J]. Cancers, 2019, 11(7):911-917.
[6]Russo A, Russano M, Franchina T, et al. Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study[J]. Adv Ther, 2020, 37 (3): 1145 -1155.
[7] Fang T , Wang Y , Yin X , et al. Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer[J]. Journal of Immunology Research, 2020, 2020(5):1-9.
[8]Miyahara Y, Takashi S, Shimizu Y, et al. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer[J]. World J Surg Oncol, 2020, 18(1):78.
[9] Vineis P,Wild CP. Global cancer patterns:causes and prevention[J]. Lancet,2014,383(9916):549-557.
[10] Onodera T,Goseki N,Kosaki G,et al.Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients[J].Nihon Geka Gakkai Zasshi,1984,85(9):1001.
[11] Ahmadi H, Djaladat H, Cai J, et al. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder[J]. Urol Oncol, 2014, 32(5): 648-656.
[12] Warren S,Gates O.Multiple primary malignant tumors:a survey of the literature and a statistical study[J].Am J Cancer 1932;16:1358-1414.
[13] Tabuchi T,Ito Y,Ioka A,et al.Tobacco smoking and the risk of subsequent primary cancer among cancer survivors: a retrospective cohort study[J]. Annals of oncology,2013,24 (10):2699-2704.
[14] Birgisson H,Pahlman L,Gunnarsson U,et al.Occurrence of second cancers in patients treated with radiotherapy for rectal cancer[J].Journal of Clinical Oncology,2005,23(25):6126-6131.
[15] Huang YJ,Huang TW,Lin FH,et al.Radiation therapy for invasive breast cancer increases the risk of second primary lung cancer:a nationwide population-based cohort analysis[J].Journal of Thoracic Oncology,2017,12(5):782-790.
[16] Fan CY,Huang WY,Lin CS,et al.Risk of second primary malignancies among patients with prostate cancer: a population-based cohort study[J].PLoS One,2017,12(4):175-217.
[17] Roxburgh CS,Mc Millan DC.Role of systemic inflammatory response in predicting survival in patients with primary operable cancer[J].Future Oncology,2010;6(1):149-163.
[18] Mantovani A,Allavena P, Sica A , et al. Cancer-related inammation[J]. Nature, 2008, 454 (7203):436-444.
[19] Grivennikov SI,Greten FR,Karin M.Immunity, inflammation, and cancer[J]. Cell, 2010, 140(6):883-899.
[20] Bindea G, Mlecnik B,Fridman WH,et al.Natural immunity to cancer in humans[J].Curr Opin Immunol,2010,22(2):215-222.
[21] Suzuki K,Aiura K,Ueda M,et al.The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents [J].Pancreas,2004,29(2):132-140.
[22] Bhindi B,Hermanns T,Wei Y,et al.Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy[J].Br J Cancer, 2016, 114: (2) 207-212.
[23] Gondo T,Nakashima J,Ohno Y,et al.Prognostic Value of Neutrophil-to-lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated With Radical Cystectomy[J].Urol,2012,79(5):1085-1091.
[24] Kwon HC,Kim SH,Oh SY,et al.Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer [J]. Biomarkers, 2012, 17 (3):216-222.
[25] Karin M.Nuclear factor-kappa B in cancer development and progression [J].Nature, 2006,441(7092):431-436
[26] Zhang GM,Zhu Y,Luo L,et al.Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy [J]. Tumor Biology, 2015,36(11):1-7.
[27] Jianfeng C,Shouzhen C,Qiyu B,et al.Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ[J].Onco Targets and Therapy,2017,10:5541-5550.